Canine IgG antibody and antigen (recombinant protein)
Diagnostic anti-Canine IgG antibodies pairs and antigen for animal health (animal Dog/Canine) testing in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT
Go to Neurodegenerative diseases diagnostics products collection >>
Product information
Catalog No. | Description | US $ Price (per mg) |
---|---|---|
GMP-CAN-IgG-Ag01 | Recombinant Canine IgG protein | 3090 |
GMP-CAN-IgG-Ab01 | Anti-Canine IgG mouse monoclonal antibody (mAb) | 1953 |
GMP-CAN-IgG-Ab02 | Anti-Canine IgG mouse monoclonal antibody (mAb) | 1953 |
GMP-CAN-IgG-Ab03 | Anti-Canine IgG human monoclonal antibody (mAb) | 1953 |
GMP-CAN-IgG-Ab04 | Anti-Canine IgG human monoclonal antibody (mAb) | 1953 |
Size: 1mg | 10mg | 100mg
Product Description
Cat No. of Products | GMP-CAN-IgG-Ag01 |
Product Name | Recombinant Canine IgG protein |
Target/Biomarker | Canine IgG (Canine IgG) |
Expression platform | E.coli |
Isotypes | Recombinant Antigen |
Bioactivity validation | Anti-Canine IgG antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in Canine IgG level test of animal Dog/Canine with N/A. |
Tag | His |
Products description | Recombinant Canine IgG protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-CAN-IgG-Ab01, GMP-CAN-IgG-Ab02 |
Product Name | Anti-Canine IgG mouse monoclonal antibody (mAb) |
Target/Biomarker | Canine IgG (Canine IgG) |
Expression platform | CHO |
Isotypes | Mouse IgG |
Bioactivity validation | Recombinant Canine IgG antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Canine IgG antibodies in Canine IgG level test of animal Dog/Canine with N/A. |
Tag | mFc |
Products description | Anti-Canine IgG mouse monoclonal antibody (mAb) is a monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Canine IgG antibodies. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-CAN-IgG-Ab03, GMP-CAN-IgG-Ab04 |
Product Name | Anti-Canine IgG human monoclonal antibody (mAb) |
Target/Biomarker | Canine IgG (Canine IgG) |
Expression platform | CHO |
Isotypes | Human IgG1 |
Bioactivity validation | Recombinant Canine IgG antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Canine IgG antibodies in Canine IgG level test of animal Dog/Canine with N/A. |
Tag | hFc |
Products description | Anti-Canine IgG human monoclonal antibody (mAb) is a monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Canine IgG antibodies. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Target/Biomarker information
Canine Immunoglobulin G (IgG) stands as a cornerstone of the intricate canine immune system. Structurally, IgG is a glycoprotein with a Y-shaped configuration, composed of two identical heavy chains and two identical light chains, linked together by disulfide bonds. Each IgG molecule boasts remarkable specificity, with its antigen-binding regions designed to recognize and bind to a vast array of pathogens. The production of IgG antibodies in dogs is a meticulously orchestrated process. B cells, a type of white blood cell, are activated when they encounter antigens—foreign substances or pathogens. Upon activation, B cells undergo a transformation, differentiating into plasma cells, which are specialized factories for IgG production. These plasma cells churn out copious amounts of IgG antibodies, which are then released into the bloodstream. Canine IgG antibodies serve as vigilant sentinels, patrolling the circulatory system and tissues, ever ready to confront invading microorganisms. When they encounter an antigen they've been designed to recognize, a cascade of events is triggered. IgG binds to the antigen with high specificity, forming an antigen-antibody complex. This interaction can have several outcomes: neutralization of the pathogen, activation of other immune cells to eliminate the threat, or marking the pathogen for destruction. One of the remarkable aspects of canine IgG is its role in providing long-lasting immunity. After an initial encounter with an antigen, memory B cells are formed. These cells "remember" the specific pathogen and can rapidly produce IgG antibodies if the same antigen enters the body again. This mechanism is the foundation of adaptive immunity and enables dogs to mount a quicker and more effective response upon reexposure to the pathogen.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.
Comments
No comments yet.